Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

 The main aim of this study was to compare magnetic resonance imaging (MRI) findings of recurrent and treatment-naïve fistula-in-ano and to correlate imaging findings with anal sphincter morphology in recurrent fistula-in-ano.  This is a retrospective study of adult patients who underwent MRI for suspected fistula-in-ano in 2018. After excluding patients with alternative diagnosis, patients were stratified into recurrent (  = 103) and treatment-naïve (  = 106) fistula-in-ano groups. Two blinded radiologists reread MRI scans in consensus for fistula characteristics and anal sphincter morphology. We compared imaging features of recurrent and treatment-naïve fistula-in-ano, assessed the incidence of anal sphincter scarring among patients with recurrent fistula-in-ano, and studied its association with fistula features.  Two-hundred nine patients (187 males) with mean age of 40.6 (standard deviation: 12.2) years were included. Trans-sphincteric, inter-sphincteric, extra-sphincteric, and supra-sphincteric fistula-in-ano were seen in 63.6, 33, 2.9, and 0.5%, respectively. There were secondary tracts, supralevator extension, and secondary cause for fistula in 49.3, 12.9, and 14.8%, respectively. There was no difference between the fistula features of recurrent and treatment-naïve fistula-in-ano, except for significantly fewer external openings among recurrent fistula-in-ano (  = 0.005). Among patients with recurrent fistula-in-ano, MRI detected anal sphincter defect/scarring was seen in 53.4% (  = 55) and was significantly associated with posterior fistula-in-ano (  = 0.031), collections and/or supralevator extension (  = 0.010), and secondary tracts (  = 0.015).  Fistula features of recurrent and treatment-naïve patients were mostly similar. There was high incidence (53.4%) of MRI-identified anal sphincter scarring/defect among recurrent fistula-in-ano, which was significantly associated with posterior fistula, collections, supra or translevator extension, and secondary tracts. MRI-identified anal sphincter scarring is very common among patients with recurrent fistula-in-ano and seen in more than half of them.There was significantly higher incidence of sphincter scarring among patients who had posterior fistula, collections, supralevator/translevator extension, and secondary tracts.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968521PMC
http://dx.doi.org/10.1055/s-0042-1758202DOI Listing

Publication Analysis

Top Keywords

recurrent fistula-in-ano
28
anal sphincter
28
treatment-naïve fistula-in-ano
16
recurrent treatment-naïve
16
secondary tracts
16
fistula-in-ano
15
features recurrent
12
sphincter scarring
12
patients recurrent
12
extension secondary
12

Similar Publications

Perianal abscess and anal fistula are debilitating surgical conditions characterized by severe pain, persistent pus discharge, and prolonged recovery periods with high recurrence rates, collectively imposing profound burdens on patients' quality of life, social functioning, and work productivity. Research has indicated potential distinction regarding the composition of gut microbiota in patients suffering from perianal abscess and anal fistula. The causal effect is yet unclear.

View Article and Find Full Text PDF

Introduction/background: For men with local recurrence of prostate cancer following radiotherapy, salvage radical prostatectomy (SRP) may be considered. However, SRP is associated with increased risk of surgical complications and patient selection is critical. To quantify this contemporary risk and identify predictive factors, we performed a retrospective cohort study utilizing the NSQIP targeted radical prostatectomy (RP) dataset.

View Article and Find Full Text PDF

Colocutaneous fistulas are a rare but challenging complication of abdominal and pelvic surgery. Their surgical management can be difficult, especially when associated with multiple failed treatments. Transanal minimally invasive surgery (TAMIS), initially designed for local excision of rectal tumors, has been increasingly used in complex benign conditions.

View Article and Find Full Text PDF

Background: Pouch-related fistulas occur in 5% to 12% of patients with ileal pouch-anal anastomosis. Although cryptoglandular and Crohn-related fistulas are commonly treated with endorectal advancement flaps, the use of pouch-advancement flaps has not been previously reported in isolation. Our aim was to evaluate the outcomes of pouch-advancement flaps in the management of pouch-related fistulas and compare the outcomes of pouch-vaginal and pouch-perineal fistulas.

View Article and Find Full Text PDF

MSI-H locally recurrent rectal cancer: Immune checkpoint inhibitors vs. standard chemotherapy and pelvic exenteration.

Dig Liver Dis

August 2025

Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. Electronic address:

Background: Locally recurrent rectal cancers (LRRC) require exenterative surgery and pelvic re-irradiation to achieve R0 margins, which are the strongest predictor of survival. Data on immune checkpoint inhibitors (ICIs) in deficient mismatch repair (dMMR)/microsatellite instability-high (MSI-H) LRRC are scarce.

Aims: To assess efficacy and short-term outcomes of pelvic exenteration and chemotherapy/(re)chemoradiation vs.

View Article and Find Full Text PDF